Cargando…
(18)F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial
INTRODUCTION: We used phase-3 CONVERT trial data to investigate the impact of fludeoxyglucose F 18 ((18)F-FDG) positron emission tomography (PET)/computed tomography (CT) in SCLC. METHODS: CONVERT randomized patients with limited-stage SCLC to twice-daily (45 Gy in 30 fractions) or once-daily (66 Gy...
Autores principales: | Manoharan, Prakash, Salem, Ahmed, Mistry, Hitesh, Gornall, Michael, Harden, Susan, Julyan, Peter, Locke, Imogen, McAleese, Jonathan, McMenemin, Rhona, Mohammed, Nazia, Snee, Michael, Woods, Sarah, Westwood, Thomas, Faivre-Finn, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616906/ https://www.ncbi.nlm.nih.gov/pubmed/31002954 http://dx.doi.org/10.1016/j.jtho.2019.03.023 |
Ejemplares similares
-
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
por: Faivre-Finn, Corinne, et al.
Publicado: (2017) -
Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2021) -
Extending routine invitation to breast screening to the 65-69 year age group: report of the Scottish pilot study
por: Dobson, HM, et al.
Publicado: (2000) -
Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial
por: Salem, Ahmed, et al.
Publicado: (2018) -
Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges
por: Payne, Heather, et al.
Publicado: (2013)